Guggenheim Starts Immunogen Inc. (IMGN) at Buy
Guggenheim analyst Michael Schmidt initiates coverage on Immunogen Inc. (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)